BNB's price fell 1.7% in 24 hours to $795, breaching the $800 support level and touching a low of $780 before bouncing slightly.
The drop comes after BNB hit a record high near $860, driven by aggressive moves into the token by public companies, including CEA Industries, Liminatus Pharma and Windtree Therapeutics.
Despite a late-session bounce, the broader market structure remains fragile, with volume patterns suggesting active rebalancing and a lack of sustained demand
